Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells
Lixian Yang(Zhejiang Provincial People's Hospital), Yuxiong Feng(Zhejiang University)
Cited by 38
Related Papers
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
|Nature Communications|2017|138
EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer
|Signal Transduction and Targeted Therapy|2019|28